Medplus Health Services Limited Asset Resilience Ratio
Medplus Health Services Limited asset resilience ratio. Medplus Health Services Limited (MEDPLUS) has an Asset Resilience Ratio of 10.54% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medplus Health Services Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medplus Health Services Limited (2019–2026)
Asset resilience ratio of Medplus Health Services Limited from 2019 to 2026. This chart shows how Medplus Health Services Limited's Asset Resilience Ratio has changed over time. Read total liabilities of Medplus Health Services Limited for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Medplus Health Services Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Medplus Health Services Limited asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs4.15 Billion | 10.54% |
| Total Liquid Assets | Rs4.15 Billion | 10.54% |
Asset Resilience Insights
- Moderate Liquidity: Medplus Health Services Limited has 10.54% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Medplus Health Services Limited Industry Peers by Asset Resilience Ratio
Compare Medplus Health Services Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SHOP APOTH. UNSP.ADR/010
F:SAE1 |
Pharmaceutical Retailers | 9.15% |
|
Redcare Pharmacy NV
F:RDC |
Pharmaceutical Retailers | 9.15% |
|
Raia Drogasil S.A
SA:RADL3 |
Pharmaceutical Retailers | 0.46% |
|
Empreendimentos Pague Menos S.A
SA:PGMN3 |
Pharmaceutical Retailers | 0.00% |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3 |
Pharmaceutical Retailers | 2.05% |
|
High Tide Inc
V:HITI |
Pharmaceutical Retailers | 0.02% |
|
Yifeng Pharmacy
SHG:603939 |
Pharmaceutical Retailers | 19.16% |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233 |
Pharmaceutical Retailers | 0.80% |
Medplus Health Services Limited Asset Resilience Ratio by Year (2019–2026)
Medplus Health Services Limited asset resilience ratio by year from 2019 to 2026. The table below shows the annual Asset Resilience Ratio data for Medplus Health Services Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 10.54% | Rs4.15 Billion ≈ $44.83 Million |
Rs39.33 Billion ≈ $425.29 Million |
+0.01pp |
| 2025-03-31 | 10.53% | Rs3.54 Billion ≈ $38.26 Million |
Rs33.60 Billion ≈ $363.38 Million |
+8.07pp |
| 2024-03-31 | 2.46% | Rs738.26 Million ≈ $7.98 Million |
Rs30.05 Billion ≈ $324.96 Million |
+0.30pp |
| 2023-03-31 | 2.16% | Rs602.99 Million ≈ $6.52 Million |
Rs27.97 Billion ≈ $302.45 Million |
-22.37pp |
| 2022-03-31 | 24.52% | Rs6.36 Billion ≈ $68.79 Million |
Rs25.94 Billion ≈ $280.54 Million |
+21.82pp |
| 2021-03-31 | 2.70% | Rs423.16 Million ≈ $4.58 Million |
Rs15.66 Billion ≈ $169.32 Million |
+0.70pp |
| 2020-03-31 | 2.00% | Rs270.30 Million ≈ $2.92 Million |
Rs13.49 Billion ≈ $145.86 Million |
-0.59pp |
| 2019-03-31 | 2.59% | Rs248.24 Million ≈ $2.68 Million |
Rs9.59 Billion ≈ $103.68 Million |
-- |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more